Mankind Pharma Shares Jump 8% as Q2 Profit Rises 38% to Rs 716 Crore

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

Mankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, supported by domestic and export growth, while EBITDA margins expanded 210 basis points.

Mankind Pharma Q2 profit rises 38% to Rs 716 crore

Mankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337.9 crore compared to ₹3,697.2 crore in the same quarter last year. This growth is attributed to strong performance in both domestic and international markets. The recent acquisition of Armed Cell Therapeutics is expected to enhance R&D capabilities.

Mankind Pharma’s quarterly profit jumps 39% on strong chronic drug demand - Regional Media News

Oct 26 (Reuters) - Indian drugmaker Mankind Pharma reported an over 39% jump in second-quarter profit on Monday, helped by strong demand for chronic therapies such as diabetes and cardiac treatments, Here are the details: • Consolidated net profit rose to 7.11 billion rupees ($74.7 [...]

Mankind Pharma Jumps 5% to Day High as Q2 Profit Rises 39%

Mankind Pharma shares jumped 5% to Rs 2,333.90 on 26 Oct following a 39% surge in September quarter profit. The board approved the numbers on 26 October. Consolidated net profit rose to Rs 711 crore, from Rs 512 crore a year earlier. Sales grew too. Revenue from operations climbed 17.3%...

Mankind Pharma Q2 Results: Net Profit Jumps 39% To Rs 711 Crore, Margin Expands

Mankind Pharma reported a 39.1% year-on-year rise in Q2 net profit to Rs 711 crore, while revenue grew 17.3% to Rs 4,338 crore.